NJ State Employees Deferred Compensation Plan’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,600
Closed -$260K 494
2022
Q1
$260K Hold
3,600
0.04% 418
2021
Q4
$331K Hold
3,600
0.04% 382
2021
Q3
$457K Hold
3,600
0.06% 301
2021
Q2
$599K Hold
3,600
0.08% 261
2021
Q1
$654K Hold
3,600
0.09% 240
2020
Q4
$720K Hold
3,600
0.11% 190
2020
Q3
$789K Sell
3,600
-5,400
-60% -$1.14M 0.14% 144
2020
Q2
$1.72M Hold
9,000
0.32% 78
2020
Q1
$1.4M Sell
9,000
-3,000
-25% -$349K 0.32% 77
2019
Q4
$1M Hold
12,000
0.17% 124
2019
Q3
$813K Hold
12,000
0.15% 137
2019
Q2
$797K Hold
12,000
0.14% 140
2019
Q1
$667K Buy
12,000
+3,000
+33% +$183K 0.12% 171
2018
Q4
$446K Buy
9,000
+3,000
+50% +$184K 0.09% 255
2018
Q3
$518K Sell
6,000
-4,000
-40% -$285K 0.09% 300
2018
Q2
$581K Sell
10,000
-4,000
-29% -$195K 0.1% 272
2018
Q1
$564K Buy
+14,000
New +$528K 0.1% 280

Other funds holding TDOC

NJ State Employees Deferred Compensation Plan's TDOC Position: Q2 2022 in Review

NJ State Employees Deferred Compensation Plan sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 3,600 shares — an estimated $260K sold.

NJ State Employees Deferred Compensation Plan first reported a position in TDOC in Q1 2018 and held it in 17 quarters. The position peaked at $1.72M in Q2 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • NJ State Employees Deferred Compensation Plan reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 3,600 Teladoc Health shares in Q2 2022, an estimated $260K.
  • NJ State Employees Deferred Compensation Plan first reported a position in Teladoc Health in Q1 2018 and held it in 17 quarters.
  • NJ State Employees Deferred Compensation Plan's Teladoc Health position peaked at $1.72M in Q2 2020.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q2 2022, filed 1 Aug 2022.